[The use of LGM-type filters inserted into the vena cava in patients with neoplasms. Preliminary report].
The aim of the study was to assess effectiveness and safety of inferior vena cava filters in patients with cancer and concurrent thromboembolic disease. The LGM filters were inserted in 10 cancer patients. Diagnosis of malignancy was established prior filter placement in 8 patients and after the procedure in 2 patients. Follow-up physical examination and ultrasound procedures (Echo, Duplex-Doppler) were performed after 1, 3, 6, 12, 24 months. Mean period of observation lasted 12 month. All patients received prolonged anticoagulation either oral anticoagulants or low molecular weight heparins after filter placement. Our results confirm that the LGM filters are effective and well tolerated in patients with malignancies. There were no important complications both early and late related to filter placement and no evidence of recurrent pulmonary emboli.
Hajduk
B
B
Kliniki Chorób Wewnetrznych, Instytutu Gruźlicy i Chorób Płuc w Warszawie.
Tomkowski
W
W
Polanowski
T
T
Oniszh
K
K
Małek
G
G
D000328:Adult; D000368:Aged; D004869:Equipment Safety; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000150:complications*; D016306:Vena Cava Filters
Zastosowanie filtrów typu LGM wszczepianych do zyły głównej dolnej u chorych na chorobe nowotworowa. Doniesienie wstepne.